 |
|
|
|
|
|
|
|
|
 |
| In the battle
against infectious disease, humankind has inadvertently given rise to deadly
enemies. Antibiotic resistance is a stunning example of evolution by natural
selection. Bacteria with traits that allow them to survive the onslaught
of drugs can thrive, re-ignite infections, and launch to new hosts on a
cough. Evolution generates a medical arms race. The bad news is that bacteria
-- with their fast doubling times and ability to swap genes like trading
cards -- evolve quickly. The good news is that in the 150 years since
Darwin, we have grown to understand the rules of the race. But can we win
this war? |
|
 |
|
|
|
|
| |
Question
submittal is now closed. Please read the panelists' answers to user-submitted questions.
|
|
| |
  |
|
|
|
 How the Roundtable Works
Four expert panelists have written statements in response to the opening question above.
Click on each panelist's name to learn about them and to read their statement.
Additional questions, both pointed and practical, were submitted by e-mail from general Web visitors and physicians alike. Panelists' answers contained a remarkable mixture of practical advice and realizations of how evolutionary theory can contribute to the future of public health.
|
|
|
|
|
|
|
|
|
